Supporting pharmacists, supporting patients: PSA releases Annual Report

The Pharmaceutical Society of Australia (PSA) continues to support pharmacists in all areas of practice and in all corners of the country, with the release of its 2022-23 Annual Report highlighting PSA’s impact on a rapidly changing pharmacy profession.

The Annual Report details PSA’s activity throughout the 2022-23 financial year to support its mission to embed, equip, and enable pharmacists to be at the forefront of healthcare in Australia.

​Releasing the report, Chief Executive Officer Adj A/Prof Steve Morris said that the report demonstrates the breadth of PSA’s work and focus on supporting members to further their practice.

​“PSA exists only because of our members, who are at the heart of everything we do from advocacy and policy development, to practice guidelines and education,” Adj A/Prof Morris said.

“As an organisation PSA has listened to members and invested heavily in our capacity to support members both at an individual practice level and as a profession.

“We are proud to be supporting members around Australia every day.

​“PSA remains focused on delivering value for our members through nation leading education, ensuring that pharmacists are at the forefront of contemporary practice as scope continues to evolve to meet patient needs.

​“In the last 12 months we have had over 100,000 enrolments in online CPD, solidifying our place as leaders in delivering high quality education to Australian pharmacists.

​“We continue to lead the conversation on medicine safety through ongoing advocacy, our flagship Medicine Safety report series, and over 40 projects and partnerships that support the Quality Use of Medicines.”

Adj A/Prof Morris specifically pointed to PSA’s significant work leading the profession with quality standards and guidelines fit for the future of pharmacy practice.

​“We are proud to have launched reimagined Professional Practice Standards, uniting every Australian pharmacist in consistent, quality pharmacy practice and demonstrating the importance of pharmacists wherever medicines are used.

​“Not only does this change the way that pharmacists engage the standards, but it also supports the continuing development of pharmacy scope of practice.”

PSA National President Dr Fei Sim FPS reflected what has been a challenging year for pharmacists.

“This is a critical period for our profession, which requires unity and strength across diverse practice areas,” Dr Sim said.

​“Over the next year and beyond, we must continue to fight for the future of the pharmacy profession, ensuring opportunities for positive career progression in all areas of practice. We must ensure that all pharmacists are supported and remunerated to continue providing the advice and services our communities rely on.

“I urge all pharmacists, from students through to experienced and advanced practice pharmacists to join us in building the future of our profession.”Dr

Must Read

New guidelines for the management of POI

0
The 2024 guidelines on diagnosing and managing premature ovarian insufficiency (POI) have been released, marking a significant advancement in women's health. Developed by the Centre...